Manufacturing

Tensive Reports Success for REGENERA Breast Scaffold Trial
Management & Regulatory Tensive Reports Success for REGENERA Breast Scaffold Trial

The pursuit of surgical solutions that prioritize long-term biological compatibility has led to a breakthrough in the field of soft tissue reconstruction with the successful completion of the latest clinical trials for the REGENERA breast scaffold. Unlike traditional synthetic implants that remain

Is Biosecurity the Key to Australia’s Economic Resilience?
Management & Regulatory Is Biosecurity the Key to Australia’s Economic Resilience?

The sudden detection of high-pathogenicity avian influenza within a commercial poultry facility in South Australia has sent ripples through the nation’s financial markets, highlighting the precarious nature of agricultural stability. This biological event serves as a stark reminder that biosecurity

Can a New Chemical Warhead Make Cancer Drugs Safer?
Research & Development Can a New Chemical Warhead Make Cancer Drugs Safer?

Modern oncology is currently witnessing a paradigm shift where the brute force of systemic chemotherapy is being replaced by sophisticated molecular delivery systems designed to spare healthy tissue. While traditional treatments often ravage the entire body to reach a localized tumor, the

Self-Sterilizing Medical Device Market to Hit $1.88B by 2030
Management & Regulatory Self-Sterilizing Medical Device Market to Hit $1.88B by 2030

Modern healthcare facilities are increasingly moving away from reactive cleaning protocols toward integrated, autonomous systems that ensure surgical instruments remain sterile during the most complex medical procedures. This fundamental shift represents a broader transformation within the global

Can SpudCell Revolutionize How We Engineer Synthetic Life?
Biotech & Bioprocessing Can SpudCell Revolutionize How We Engineer Synthetic Life?

The recent emergence of SpudCell represents a profound shift in biotechnological history, effectively moving beyond the mere observation of life to the construction of a self-sustaining autonomous entity. Developed by dedicated researchers at the University of Minnesota, this first-of-its-kind

Airlift Bioreactors Market to Reach $8.2 Billion by 2035
Biotech & Bioprocessing Airlift Bioreactors Market to Reach $8.2 Billion by 2035

The global biopharmaceutical landscape is currently undergoing a transformative phase where the demand for precision-engineered therapeutic proteins and complex cellular products has outpaced the capabilities of traditional fermentation systems. This shift is most evident in the rapid adoption of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later